Ziopharm Oncology reported $3.5M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.23B 197M
AstraZeneca AZN:LN 3.06B 1.03B
Baxter International BAX:US $ 790M 90M
Biogen BIIB:US $ 634.9M 153M
Bioline Rx BLRX:US 1.64M 172K
Bristol Myers Squibb BMY:US $ 1.83B 523M
Corcept Therapeutics CORT:US $ 37.55M 5.26M
Curis CRIS:US $ 5.67M 900K
Eleven Biotherapeutics EBIO:US 8.98M 379K
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Immunogen IMGN:US $ 16.65M 3.07M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Intrexon XON:US $ 19.58M 2.81M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Merk MRK:US $ 2.3B 518M
Novartis NOVN:VX 3.5B 486M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Tg Therapeutics TGTX:US $ 20.61M 11.8M
Verastem VSTM:US $ 5.93M 274K
YTE INCY:US $ 209.58M 16.62M
Ziopharm Oncology ZIOP:US $ 3.5M 1.41M